ITW vs SLRX · P/E 22, rev $8.32B vs $4.9M cap
Illinois Tool Works Inc (ITW) versus Salarius Pharmaceuticals Inc (SLRX) — a side-by-side from cached financials, not a winner call.
Illinois Tool Works Inc (ITW) is a specialty industrial machinery company listed on US.
Salarius Pharmaceuticals Inc (SLRX) is a biotechnology company listed on NASDAQ.
Latest reported ITW revenue for 2026-06-30 was $8.32B. Net income was $1.58B. ITW currently screens at market cap $72.53B and trailing P/E 21.8.
Latest reported SLRX revenue for 2023-03-31 was $0. Net income was -$5.3M. SLRX currently screens at market cap $4.9M.
ITW currently screens at market cap $72.53B and trailing P/E 21.8. SLRX currently screens at market cap $4.9M.
Not investment advice. Open the ITW and SLRX stock pages for the full models.
Not investment advice.